Chargement en cours...
Cardiovascular disease risk factors among transgender women in Chiang Mai, Thailand
Transgender individuals take hormone therapy (HT) for transitioning secondary sexual characteristics, especially by transgender women assigned male at birth (AMAB). The transgender drug is a relatively new field in health care, but limited data exist to inform the cardiovascular risk factor profile...
Enregistré dans:
| Publié dans: | Am J Cardiovasc Dis |
|---|---|
| Auteurs principaux: | , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
e-Century Publishing Corporation
2020
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7364281/ https://ncbi.nlm.nih.gov/pubmed/32685270 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|